Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793464 · ClinicalTrials.gov registry record · NA
COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos)
A NA study, sponsored by University of Oregon.
- Completed
- Registry status
- NA
- Development phase
- 1,623
- Enrollment target
NCT04793464: Completed NA study, sponsored by University of Oregon.
NCT04793464 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 1,623 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04793464, a NA study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,623 participants
- Enrollment target
Study Summary
The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis that the United States has faced in a century. Although this highly contagious virus has infected millions of Americans already, the disease burdens are disproportionately born by historically underserved populations such as Latinx communities. This disparity is notable in Oregon, where the 13% of the population that is Latinx represents approximately 44% of COVID-19 cases. An urgent need exists to reach Oregon's Latinx community to prevent SARS-CoV-2 transmission. The overall goal of this study is to implement a Promotores de Salud intervention to increase the reach, access, uptake, and impact of testing in Latinx communities in Oregon. This project will fully integrate with the National institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) consortium and its Coordination and Data Collection Center (CDCC). With guidance and leadership from the study's Latinx Community and Scientific Advisory Board, 38 testing sites have been established to test the Promotores de Salud intervention. The investigators will test whether the Promotores de Salud intervention will increase testing rates and promote better health behaviors in communities over time. The investigators will test the intervention using a randomized control trial comparing the intervention to county outreach services as usual. Evaluation of the Promotores de Salud intervention held during a testing event (compared to distribution of a pamphlet only) will test whether culturally competent education results in greater use of strategies that reduce transmission of COVID-19 at the community and individual level. The investigators have designed a working group structure with teams focused on: Community Engagement, Molecular Biology, Data Science, and Implementation Science. These working groups are coordinated by an Administrative Hub and guided by the study's Latinx Community and Scientific
Primary Outcome
From the PhenX toolkit, Protocol - COVID-19 Knowledge, Attitudes, and Avoidant Behaviors, participants are asked to indicate "Which of the following have you done in the last even days to keep yourself safe from coronavirus? Only consider actions that you took or decisions that you made personally." There are a total of 17 possible items participants rate as a binary, Yes/No, response. The count of 'yes' responses was recorded. The scale will range from 0-17. A higher score indicates more preven
Interventions
- BEHAVIORAL Services as usual
- BEHAVIORAL Promotores de Salud
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,623 participants |
| Start Date | 2021-02-04 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04793464 record still lists
NCT04793464 is an interventional study that assigns participants to a tested intervention. Its 1,623 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher).
The record links to 0 conditions, and to 2 interventions - of which Services as usual is the first listed.
NCT04793464 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04793464 about?
NCT04793464 is a clinical study titled "COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos)". The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis that the United States has faced in a century. Although this highly contagious virus has infected millions of Americans already, the disease burdens are disproportionately born by historical...
What is the current status of trial NCT04793464?
This trial is currently completed. It is a NA study. The enrollment target is 1,623 participants. The study started on 2021-02-04. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04793464?
The interventions under investigation include: Services as usual (BEHAVIORAL), Promotores de Salud (BEHAVIORAL).
Who is sponsoring clinical trial NCT04793464?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04793464's enrollment target sits among peer trials
1,623 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI